Chanel Jacklyn Perkins, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Orthopedics Dept, Galveston, TX 77555 Phone: 409-747-5701 Fax: 409-747-5715 |
Dr. Gary Scott Bucholz, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1617 Tremont St, Galveston, TX 77550 Phone: 409-762-4941 Fax: 409-762-7715 |
Dr. John G Knecht Ii, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1529 39th St, Galveston, TX 77550 Phone: 409-762-6433 Fax: 409-762-8245 |
Premiere Pointe Podiatry, Pllc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 1529 39th St, Galveston, TX 77550 Phone: 409-762-6433 |
Oluwatosin A Ogunlana, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222 |
Door Docs, Pllc Podiatrist - Primary Podiatric Medicine Medicare: Medicare Enrolled Practice Location: 4920 Seawall Blvd Ste B, Galveston, TX 77551 Phone: 281-699-3323 Fax: 281-699-3276 |
John G Knecht, Dpm Pa Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1529 39th St, Galveston, TX 77550 Phone: 409-762-6433 Fax: 409-762-8245 |
Island Foot And Ankle, Pllc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 4920 Seawall Blvd Ste B, Galveston, TX 77551 Phone: 409-405-1977 Fax: 409-405-1728 |
News Archive
Californians upset with Gov. Gavin Newsom's pandemic rules — which shuttered businesses, kept schoolkids at home and mandated masks — helped fuel the September recall election that could spell the end of his political career.
MEDIAN Technologies, a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials and clinical routine, announced today it will demonstrate its Lesion Management Solutions -LMS- clinical application portfolio together with Canon at ITEM, April 13-15, 2012 in Yokohama, Japan.
Bioconnect Systems, Inc. announced today that data from the Company's first clinical study will be presented this week at the ASN Meeting in San Diego. Bioconnect's implant platform, the Optiflow™, enhances a surgeon's ability to create precise vascular connections.
Mylan Inc. today announced that it has received all regulatory approvals and has completed an agreement with Pfizer for the exclusive worldwide rights to develop, manufacture and commercialize a novel long-acting muscarinic antagonist compound for various indications.
Kaiser Health News provides a fresh take on health policy developments with "Focus, Focus, Focus" by Mike Luckovich.
› Verified 7 days ago